You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: October 24, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Famotidine, and what generic alternatives are available?

Famotidine is a drug marketed by Hi-tech Pharma Co, Lupin Ltd, Navinta Llc, Novel Labs Inc, Apotex Inc, Apothecon, Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, West-ward Pharms Int, Perrigo, Actavis Elizabeth, Alembic Pharms Ltd, Apotex, Aurobindo Pharma Ltd, Carlsbad, Celltrion, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, P And L, Perrigo R And D, Pld Acquisitions, Sandoz, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Watson Labs, Wockhardt, Abbvie, and Baxter Hlthcare. and is included in sixty NDAs.

The generic ingredient in FAMOTIDINE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

Drug patent expirations by year for FAMOTIDINE
Drug Prices for FAMOTIDINE

See drug prices for FAMOTIDINE

Drug Sales Revenue Trends for FAMOTIDINE

See drug sales revenues for FAMOTIDINE

Recent Clinical Trials for FAMOTIDINE

Identify potential brand extensions & 505(b)(2) entrants

drpykessupplements.comPhase 4
Novotech (Australia) Pty LimitedPhase 1
Calithera Biosciences, IncPhase 1

See all FAMOTIDINE clinical trials

Pharmacology for FAMOTIDINE
Medical Subject Heading (MeSH) Categories for FAMOTIDINE
Paragraph IV (Patent) Challenges for FAMOTIDINE
Tradename Dosage Ingredient NDA Submissiondate
PEPCID TABLET;ORAL famotidine 019462

US Patents and Regulatory Information for FAMOTIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira FAMOTIDINE PRESERVATIVE FREE famotidine INJECTABLE;INJECTION 075669-001 Apr 16, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc FAMOTIDINE famotidine TABLET;ORAL 075457-001 Apr 18, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd FAMOTIDINE famotidine TABLET;ORAL 077367-002 Aug 17, 2001 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.